Outcome measures of Chinese herbal medicine for hypertension: An overview of systematic reviews

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Wang, Jie ^a   Xiong, Xingjiang ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIDENS BIPINNATA; CHINESE DRUG; HERBACEOUS AGENT; NIUHUANG JIANGYA; PINGGAN JIANGYA; PINGJIANGYIN; QINRE JIANGYA; TIANMA GOUTENG; TIAOPINGKANG; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; GERIATRIC DISORDER; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE PRESSURE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84872798783     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/697237     Document Type: Review

References (55)

1. Sliwa K., Stewart S., Gersh B. J., Hypertension: a global perspective. Circulation 2011 123 24 2892 2896 2-s2.0-79959509371 10.1161/CIRCULATIONAHA.110. 992362
2. MacMahon S., Alderman M. H., Lindholm L. H., Liu L., Sanchez R. A., Seedat Y. K., Blood-pressure-related disease is a global health priority. The Lancet 2008 371 9623 1480 1482 2-s2.0-43049147142 10.1016/S0140-6736(08)60632-7 (Pubitemid 351626171)
3. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
4. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
5. Xu H., Chen K. J., Complementary and alternative medicine: is it possible to be mainstream? Chinese Journal of Integrative Medicine 2012 18 6 403 404 10.1007/s11655-012-1126-7
6. Weil A., The state of the integrative medicine in the U.S. and Western World. Chinese Journal of Integrative Medicine 2011 17 1 6 10 2-s2.0-79952552315 10.1007/s11655-011-0600-y
7. Keji C., Hao X., The integration of traditional Chinese medicine and Western medicine. European Review 2003 11 2 225 235 2-s2.0-0038115317 10.1017/S106279870300022X (Pubitemid 36715496)
8. Cheung F., TCM: made in China. Nature 2011 480 7378, supplement S82 S83
9. Xu H., Chen K., Integrative medicine: the experience from China. Journal of Alternative and Complementary Medicine 2008 14 1 3 7 2-s2.0-38749126248 10.1089/acm.2006.6329 (Pubitemid 351185427)
10. Robinson N., Integrative medicine-traditional Chinese medicine, a model? Chinese Journal of Integrative Medicine 2011 17 1 21 25 10.1007/s11655-011-0602- 9
11. Chen K. J., Where are we going? Chinese Journal of Integrative Medicine 2010 16 2 100 101 2-s2.0-77954528292 10.1007/s11655-010-0100-5
12. Dobos G., Tao I., The model of western integrative medicine: the role of Chinese medicine. Chinese Journal of Integrative Medicine 2011 17 1 11 20 2-s2.0-79952542879 10.1007/s11655-011-0601-x
13. Eisenberg D., Reflections on the past and future of integrative medicine from a lifelong student of the integration of Chinese and Western medicine. Chinese Journal of Integrative Medicine 2011 17 1 3 5 2-s2.0-79952561788 10.1007/s11655-011-0622-5
14. Sun X. G., Wu W. K., Lu Z. P., Chinese integrative medicine: translation toward person centered and balanced medicine. Chinese Journal of Integrative Medicine 2012 18 1 3 6 10.1007/s11655-012-0961-x
15. Wang J., Wang P. Q., Xiong X. J., Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine 2012 2 3 10.4172/2165-8048.1000113
16. Xu H., Chen K. J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine 2011 17 2 83 84 2-s2.0-79952558248 10.1007/s11655-011-0641-2
17. Wang J., Xiong X. J., Current situation and perspectives of clinical study in integrative medicine in China. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 268542 10.1155/2012/268542
18. Bell R. A., Suerken C. K., Grzywacz J. G., Lang W., Quandt S. A., Arcury T. A., CAM use among older adults age 65 or older with hypertension in the United States: general use and disease treatment. Journal of Alternative and Complementary Medicine 2006 12 9 903 909 2-s2.0-33751080093 10.1089/acm.2006.12. 903 (Pubitemid 44770983)
19. Ernst E., Complementary/alternative medicine for hypertension: a mini-review. Wiener Medizinische Wochenschrift 2005 123 386 391 (Pubitemid 41482719)
20. Park J. J., Beckman-Harned S., Cho G., Kim D., Hangon Kim, The current acceptance, accessibility and recognition of Chinese and Ayurvedic medicine in the United States in the public, governmental, and industrial sectors. Chinese Journal of Integrative Medicine 2012 18 6 405 408 10.1007/s11655-012-1110-2
21. Wang J., Xiong X. J., Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 284847 10.1155/2012/284847
22. Xu H., Chen K. J., Making evidence-based decisions in the clinical practice of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 6 483 485 2-s2.0-79952569703 10.1007/s11655-010-0560-7
23. Liu M. Y., Chen K. J., Convergence: the tradition and the modern. Chinese Journal of Integrative Medicine 2012 18 3 164 165 10.1007/s11655-012-1014-1
24. Williamson P., Clarke M., The COMET (Core Outcome Measures in Effectiveness Trials) Initiative: its role in improving Cochrane Reviews. Cochrane Database of Systematic Reviews 2012 5 ED000041
25. Smyth R. M., Kirkham J. J., Jacoby A., Altman D. G., Gamble C., Williamson P. R., Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ 2011 342 c7153 2-s2.0-79952241065 10.1136/bmj.c7153
26. Moher D., Liberati A., Tetzlaff J., Altman D. G., Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. PLOS Medicine 2009 6 7 e1000097
27. Wang H., Shang H. C., Zhang J. H., Chen J., Sun B. Z., Shang D. D., Xiang Y. Z., Cao H. B., Ren M., Guo L. P., Zhang B. L., Niuhuang Jiangya preparation for treatment of essential hypertension: a systematic review Liaoning Zhong Yi Za Zhi 2008 35 5 649 652
28. Hu Y. X., Quantitative analysis of clinical controlled trials of traditional Chinese medicine and systematic evaluation of randomized controlled trials involving traditional Chinese medicine for essential hypertension, [M.S. thesis] 2009 Guangzhou, China Guangzhou University of Chinese Medicine
29. Ren Y., Ou A. H., Lin X. Z., Lao Y. R., Meta-analysis of traditional Chinese medicine for essential hypertension Shanxi Zhong Yi 2006 27 7 794 796
30. Dong D. X., Yao S. L., Yu N., Yang B., Systematic review and meta-analysis of Tianma Gouteng Yin combined with enalapril for essential hypertension Zhongguo Zhong Yi Ji Zheng 2011 20 5 762 764
31. Zhang H. W., Tong J., Zhou G., Jia H., Jiang J. Y., Tianma Gouteng Yin formula for treating primary hypertension. Cochrane Database of Systematic Reviews 2012 6 CD008166 10.1002/14651858.CD008166
32. Xu W. J., Li Y. L., Systematic review of clinical evidence about calm the liver and subdue yang therapy on the hypertension disease with syndrome of upper hyperactivity of liver yang Zhonghua Zhong Yi Yao Za Zhi 2012 27 3 736 739
33. Shi M., Zhang Y. H., Systematic review of replenishing kidney qi method for essential hypertension with kidney qi deficiency syndrome Shandong Zhong Yi Za Zhi 2012 31 4 236 238
34. Liu L., Li Y. L., Systematic review on treatment of essential hypertension from spleen and kidney deficiency Zhonghua Zhong Yi Yao Za Zhi 2011 26 8 1700 1703
35. Li D. N., Yang C. H., Effects of Chinese medicine on elderly isolated systolic hypertension: a meta-analysis Liaoning Zhong Yi Za Zhi 2012 39 5 812 815
36. Han S. H., Evaluation of integrated Chinese and western medicine in treatment of hypertension in the elderly and their life quality, [M.S. thesis] 2011 Beijing, China China Academy of Chinese Medical Sciences
37. Higgins J. P. T., Green S., Cochrane handbook for systematic reviews of interventions. version 5. 1. 0, The Cochrane Collaboration, 2009, http://www.cochrane-handbook.org/
38. Clarke M., Standardising outcomes for clinical trials and systematic reviews. Trials 2007 8 article no. 39 2-s2.0-37749001159 10.1186/1745-6215-8-39
39. Veitch E., The science of outcomes: how far have we come? http://blogs.plos.org/speakingofmedicine/2011/07/15/the-science-of-outcomes-how- far-have-we-come/
40. Chen K. J., Clinical service of Chinese medicine. Chinese Journal of Integrative Medicine 2008 14 3 163 164 2-s2.0-54549099086 10.1007/s11655-008- 0163-8
41. Chan K., Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003 52 9 1361 1371 2-s2.0-0642283441 10.1016/S0045-6535(03)00471-5 (Pubitemid 41123338)
42. Zhang L., Yan J. B., Liu X. M., Ye Z. G., Yang X. H., Meyboom R., Chan K., Shaw D., Duez P., Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective. Journal of Ethnopharmacology 2012 140 3 519 525 10.1016/j.jep.2012.01.058
43. Xu H., Chen K. J., Herb-drug interaction: an emerging issue of integrative medicine. Chinese Journal of Integrative Medicine 2010 16 3 195 196 2-s2.0-78149421985 10.1007/s11655-010-0195-z
44. Wang J., van der Heijden R., Spruit S., Hankermeier T., Chan K., van der Greef J., Xu G., Wang M., Quality and safety of Chinese herbal medicines guided by a systems biology perspective. Journal of Ethnopharmacology 2009 126 1 31 41 2-s2.0-70349787170 10.1016/j.jep.2009.07.040
45. Melchart D., Linde K., Hager S., Shaw D., Bauer R., Liver enzyme elevations in patients treated with traditional Chinese medicine. Journal of the American Medical Association 1999 282 1 28 29 2-s2.0-0033532985 10.1001/jama.282.1.28 (Pubitemid 29318925)
46. Green S., Higgins J. P. T., Alderson P., Cochrane Handbook 2008 version 5.0.1 The Cochrane Library
47. The Cochrane Collaboration, Cochrane reviews. 2011, http://www.cochrane. org/cochrane-reviews/
48. Luo J., Xu H., Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 927392 10.1155/2012/927392
49. Qiu Y., Xu H., Shi D. Z., Traditional Chinese herbal products for coronary heart disease: an overview of Cochrane Reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 417387 10.1155/2012/417387
50. Hu J., Zhang J. H., Zhao W., Zhang Y. L., Zhang L., Shang H. C., Cochrane systematic reviews of Chinese herbal medicines: an overview. PLoS One 2011 6 12 e28696 10.1371/journal.pone.0028696
51. Ma B., Guo J., Qi G., Li H., Peng J., Zhang Y., Ding Y., Yang K., Epidemiology, quality and reporting characteristics of systematic reviews of traditional Chinese medicine interventions published in Chinese journals. PLoS One 2011 6 5 e20185 10.1371/journal.pone.0020185
52. He J., Du L., Liu G., Fu J., He X., Yu J., Shang L., Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews. Trials 2011 12 article no. 122 2-s2.0-79955831709 10.1186/1745-6215-12-122
53. Junhua Z., Hongcai S., Xiumei G., Boli Z., Yaozu X., Hongbo C., Ming R., Methodology and reporting quality of systematic review/meta-analysis of traditional Chinese medicine. Journal of Alternative and Complementary Medicine 2007 13 8 797 805 2-s2.0-35948979969 10.1089/acm.2007.7195 (Pubitemid 350071613)
54. Wang J., Yao K. W., Yang X. C., Liu W., Feng B., Ma J. Z., Du X. L., Wang P. Q., Xiong X. J., Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 10.1155/2012/714805 714805
55. Schulz K. F., Altman D. G., Moher D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine 2010 7 3 e1000251 2-s2.0-77952774030 10.1371/journal.pmed.1000251